Immunotherapy— A Powerful Tool in the Fight Against Cancer

Best Practices in Immunotherapy – June/July 2017 Vol 8
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Editor-in-Chief, JONS; Co-Founder, AONN+; University Distinguished Service Professor of Breast Cancer, Professor of Surgery, Johns Hopkins University School of Medicine; Co-Developer, Work Stride-Managing Cancer at Work, Johns Hopkins Healthcare Solutions

Dear Navigators,

On behalf of the JONS Editorial Board, it is my pleasure to present this special edition dedicated to the topic of immunotherapy. One of the many responsibilities of a navigator is to facilitate patient education—it is therefore imperative that we educate ourselves on new treatments, distill the information into lay terms, and use that information to effectively educate our patients.

I know that when patients initially receive a cancer diagnosis, among the barrage of thoughts and fears that simultaneously strike them is the assumption that they will receive chemotherapy. Whereas at one time chemotherapy was one of our only weapons in the fight against cancer, that is not true today. And while chemotherapies remain an effective tool, they are joined by other therapy options, including immunotherapies.

There are several types of immunotherapies, including monoclonal antibodies, immune checkpoint inhibitors, and therapeutic vaccines. All have the goal of empowering the body’s own immune system to fight cancer. Much of the information on immunotherapies is highly scientific in nature and presented in scholarly or academic venues, so it is important for navigators to find the correct tools to help our patients attain a thorough understanding of this therapeutic option in language that is accessible.

Immunotherapies are an important new weapon in our arsenal, and as navigators, we are obligated to learn all we can about them. I hope this issue increases your understanding of this exciting area of oncology treatment.

Sincerely,

Lillie Digital Signature

Lillie D. Shockney, RN, BS, MAS, ONN-CG
Editor-in-Chief, JONS; Program Director, AONN+
University Distinguished Service Professor of Breast Cancer; Administrative Director, the Johns Hopkins Breast Center; Director, Cancer Survivorship
Programs at the Sidney Kimmel Cancer Center at Johns Hopkins; Professor, JHU School of Medicine, Depts of Surgery and Oncology; Cofounder, Johns Hopkins Medicine Managing Cancer at Work.
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Related Articles
National Nurses Month: Celebrating the Impact of Nurses
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
|
May 2023 Vol 14, No 5
All day, every day, nurses make all the difference in delivering high-quality care to those who need it the most. On behalf of all of us at AONN+, I want to recognize the nurses in our community for their invaluable contributions to healthcare.
Will Your Team Receive an Exceptional Research in Navigation Award?
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
|
April 2023 Vol 14, No 4
The abstract submission portal is open, and our expert peer-reviewers are standing by, awaiting your evidence-based navigation research studies, quality improvement projects, and best practices to consider for inclusion at the AONN+ Annual Conference.
A Community of Navigators, 2.1K Strong!
March 2023 Vol 14, No 3
I would like to extend a personal invitation to each of you to join our private AONN+ Facebook group.
Last modified: November 15, 2022

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country